ACGM	American College of Medical Genetics and Genomics
ALK	Anaplastic lymphoma kinase
EGFR	Epidermal growth factor receptor
FFPE	Formalin-fixed, paraffin-embedded
HR	Hazard ratio
ICI	Immune-checkpoint inhibitor
IHC	Immunohistochemistry
IL-1β	Interleukin-1β
MMR	Mismatch repair
MSI	Microsatellite stability
NGS	Next-generation sequencing
NSCLC	Non-small cell lung cancer
OS	Overall survival
PD-L1	Programmed death-ligand 1
Q1	Low (lowest 25%) IL-1β expression
Q4	High (highest 25%) IL-1β expression
TKI	Tyrosine kinase inhibitor
TME	Tumor microenvironment
TOT	Time on treatment
TPS	Tumor proportion score